Dennis Jilins
business executive0.0Global Dominance: 0.00%
Dennis Jilins is a board advisor for Huya Bio, a company focused on biopharmaceutical innovation. He remarked at the 2025 Zhongguancun Forum that China's substantial investments in life sciences research have established a competitive foundation for global participation in the biopharmaceutical industry.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dennis Jilins, a board advisor at Huya Bio, noted the significant investments in life sciences research in China.
共同探索互利共赢的全球科技合作新模式 --国际--人民网People's Daily·
China· 2025-04-02
China· 2025-04-02
